These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25677051)

  • 1. Reduced cross-protection against influenza A(H3N2) subgroup 3C.2a and 3C.3a viruses among Finnish healthcare workers vaccinated with 2013/14 seasonal influenza vaccine.
    Haveri A; Ikonen N; Julkunen I; Kantele A; Anttila V; Ruotsalainen E; Nohynek H; Lyytikainen O; Savolainen-Kopra C
    Euro Surveill; 2015 Feb; 20(5):21028. PubMed ID: 25677051
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibodies cross-reactive to influenza A (H3N2) variant virus and impact of 2010-11 seasonal influenza vaccine on cross-reactive antibodies - United States.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Apr; 61(14):237-41. PubMed ID: 22495226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV).
    Skowronski DM; Sabaiduc S; Leir S; Rose C; Zou M; Murti M; Dickinson JA; Olsha R; Gubbay JB; Croxen MA; Charest H; Bastien N; Li Y; Jassem A; Krajden M; De Serres G
    Euro Surveill; 2019 Nov; 24(46):. PubMed ID: 31771709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ineffectiveness of the 2014-2015 H3N2 influenza vaccine.
    Mandelboim M; Glatman-Freedman A; Drori Y; Sherbany H; Pando R; Sefty H; Zadka H; Shohat T; Keller N; Mendelson E
    Oncotarget; 2016 Jan; 7(2):1185-92. PubMed ID: 26716420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interim estimates of divergence date and vaccine strain match of human influenza A(H3N2) virus from systematic influenza surveillance (2010-2015) in Hangzhou, southeast of China.
    Li J; Zhou YY; Kou Y; Yu XF; Zheng ZB; Yang XH; Wang HQ
    Int J Infect Dis; 2015 Nov; 40():17-24. PubMed ID: 26417878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in genetically drifted H3N2 influenza A viruses and vaccine effectiveness in adults 65 years and older during the 2016/17 season in Denmark.
    Trebbien R; Fischer TK; Krause TG; Nielsen L; Nielsen XC; Weinreich LS; Lis-Tønder J; Skov MN; Christiansen CB; Emborg HD
    J Clin Virol; 2017 Sep; 94():1-7. PubMed ID: 28697450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with 2014-15 Seasonal Inactivated Influenza Vaccine Elicits Cross-Reactive Anti-HA Antibodies with Strong ADCC Against Antigenically Drifted Circulating H3N2 Virus in Humans.
    Zhong W; Gross FL; Holiday C; Jefferson SN; Bai Y; Liu F; Katz JM; Levine MZ
    Viral Immunol; 2016 May; 29(4):259-62. PubMed ID: 26950058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018.
    Skowronski DM; Chambers C; De Serres G; Dickinson JA; Winter AL; Hickman R; Chan T; Jassem AN; Drews SJ; Charest H; Gubbay JB; Bastien N; Li Y; Krajden M
    Euro Surveill; 2018 Feb; 23(5):. PubMed ID: 29409570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trivalent inactivated influenza vaccine effective against influenza A(H3N2) variant viruses in children during the 2014/15 season, Japan.
    Sugaya N; Shinjoh M; Kawakami C; Yamaguchi Y; Yoshida M; Baba H; Ishikawa M; Kono M; Sekiguchi S; Kimiya T; Mitamura K; Fujino M; Komiyama O; Yoshida N; Tsunematsu K; Narabayashi A; Nakata Y; Sato A; Taguchi N; Fujita H; Toki M; Myokai M; Ookawara I; Takahashi T
    Euro Surveill; 2016 Oct; 21(42):. PubMed ID: 27784529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017.
    Skowronski DM; Chambers C; Sabaiduc S; Dickinson JA; Winter AL; De Serres G; Drews SJ; Jassem A; Gubbay JB; Charest H; Balshaw R; Bastien N; Li Y; Krajden M
    Euro Surveill; 2017 Feb; 22(6):. PubMed ID: 28205503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season.
    Skowronski DM; Janjua NZ; De Serres G; Winter AL; Dickinson JA; Gardy JL; Gubbay J; Fonseca K; Charest H; Crowcroft NS; Fradet MD; Bastien N; Li Y; Krajden M; Sabaiduc S; Petric M
    Clin Infect Dis; 2012 Aug; 55(3):332-42. PubMed ID: 22539661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza vaccine effectiveness against medically attended influenza illness in Beijing, China, 2014/15 season.
    Ma C; Pan Y; Zhang L; Zhang Y; Wu S; Sun Y; Duan W; Zhang M; Wang Q; Yang P
    Hum Vaccin Immunother; 2017 Oct; 13(10):2379-2384. PubMed ID: 28846480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings: A test-negative case-control study in Beijing, China, 2016/17 season.
    Wu S; Pan Y; Zhang X; Zhang L; Duan W; Ma C; Zhang Y; Zhang M; Sun Y; Yang P; Wang Q; Ma J
    Vaccine; 2018 Sep; 36(38):5774-5780. PubMed ID: 30087046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interim estimates of the effectiveness of the influenza vaccine against A(H3N2) influenza in adults in South Korea, 2016-2017 season.
    Noh JY; Lim S; Song JY; Choi WS; Jeong HW; Heo JY; Lee J; Seo YB; Lee JS; Wie SH; Kim YK; Park KH; Jung SI; Kim SW; Lee SH; Lee HS; Yoon YH; Cheong HJ; Kim WJ
    PLoS One; 2017; 12(5):e0178010. PubMed ID: 28542417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15-64-year-olds in Europe: exploration by birth cohort.
    Kissling E; Pozo F; Buda S; Vilcu AM; Gherasim A; Brytting M; Domegan L; Gómez V; Meijer A; Lazar M; Vučina VV; Dürrwald R; van der Werf S; Larrauri A; Enkirch T; O'Donnell J; Guiomar R; Hooiveld M; Petrović G; Stoian E; Penttinen P; Valenciano M;
    Euro Surveill; 2019 Nov; 24(48):. PubMed ID: 31796152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results.
    Andrews N; McMenamin J; Durnall H; Ellis J; Lackenby A; Robertson C; von Wissmann B; Cottrell S; Smyth B; Moore C; Gunson R; Zambon M; Fleming D; Pebody R
    Euro Surveill; 2014 Jul; 19(27):5-13. PubMed ID: 25033051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of prior seasonal H3N2 influenza vaccination or infection on protection and transmission of emerging variants of influenza A(H3N2)v virus in ferrets.
    Houser KV; Pearce MB; Katz JM; Tumpey TM
    J Virol; 2013 Dec; 87(24):13480-9. PubMed ID: 24089569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid-season results.
    Pebody RG; Warburton F; Ellis J; Andrews N; Thompson C; von Wissmann B; Green HK; Cottrell S; Johnston J; de Lusignan S; Moore C; Gunson R; Robertson C; McMenamin J; Zambon M
    Euro Surveill; 2015 Feb; 20(5):21025. PubMed ID: 25677050
    [No Abstract]   [Full Text] [Related]  

  • 19. Mid-season real-time estimates of seasonal influenza vaccine effectiveness in persons 65 years and older in register-based surveillance, Stockholm County, Sweden, and Finland, January 2017.
    Hergens MP; Baum U; Brytting M; Ikonen N; Haveri A; Wiman Å; Nohynek H; Örtqvist Å
    Euro Surveill; 2017 Feb; 22(8):. PubMed ID: 28251891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ιnfluenza A(H3N2) genetic variants in vaccinated patients in northern Greece.
    Melidou A; Gioula G; Exindari M; Ioannou E; Gkolfinopoulou K; Georgakopoulou T; Tsiodras S; Papa A
    J Clin Virol; 2017 Sep; 94():29-32. PubMed ID: 28734139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.